Virothera
Pre-clinicalVirothera Ltd, a biotech start-up, is developing discoveries by the founder in targeting advancement of immune cells by human homologues of virus immune modifiers. These aim to solve problems of regulating immune response in vivo leading to new breakthrough immunotherapies to durably control recurring persistent disease. Using a gene therapy approach has potential to greatly extend the reach and accessibility over current cell or antibody based modalities.
Private Company
Funding information not available
About
Virothera Ltd, a biotech start-up, is developing discoveries by the founder in targeting advancement of immune cells by human homologues of virus immune modifiers. These aim to solve problems of regulating immune response in vivo leading to new breakthrough immunotherapies to durably control recurring persistent disease. Using a gene therapy approach has potential to greatly extend the reach and accessibility over current cell or antibody based modalities.